2008•Clinical DiabetesRequires access

Punch Skin Biopsy in Diabetic Neuropathy

Michael J. Polydefkis

Open publisher page 2 citations

Abstract

Measurement of unmyelinated C and A delta nociceptors through punch skin biopsy has been an important development in diabetic peripheral neuropathy over the past decade. The technique provides an objective pathological window into a population of fibers that is invisible to standard electrophysiological techniques and as a result has been difficult to investigate. Clinically, the punch biopsy technique is most often used to define a length-dependent peripheral neuropathy, but can also be used to follow patients longitudinally over time. Epidermal nerve fibers are often lost early in diabetes or impaired glucose tolerance and can be the only objective measure of neuropathy in these patients. The accessibility of cutaneous nerve fibers has also given rise to several nerve injury paradigms from which regeneration can be efficiently measured. The chapter will review the skin biopsy technique and recent findings with respect to diabetes.

About this research paper

What this paper is about

Measurement of unmyelinated C and A delta nociceptors through punch skin biopsy has been an important development in diabetic peripheral neuropathy over the past decade. The technique provides an objective pathological window into a population of fibers that is invisible to standard electrophysiological techniques and as a result has been difficult to investigate. Clinically, the punch biopsy technique is most often used to define a length-dependent peripheral neuropathy, but can also be used to follow patients longitudinally over time. Epidermal nerve fibers are often lost early in diabetes or impaired glucose tolerance and can be the only objective measure of neuropathy in these patients. The accessibility of cutaneous nerve fibers has also given rise to several nerve injury paradigms from which regeneration can be efficiently measured. The chapter will review the skin biopsy technique and recent findings with respect to diabetes.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Measurement of unmyelinated C and A delta nociceptors through punch skin biopsy has been an important development in diabetic peripheral neuropathy over the past decade. The technique provides an objective pathological window into a population of fibers that is invisible to standard electrophysiological techniques and as a result has been difficult to investigate. Clinically, the punch biopsy technique is most often used to define a length-dependent peripheral neuropathy, but can also be used to follow patients longitudinally over time. Epidermal nerve fibers are often lost early in diabetes or impaired glucose tolerance and can be the only objective measure of neuropathy in these patients. The accessibility of cutaneous nerve fibers has also given rise to several nerve injury paradigms from which regeneration can be efficiently measured. The chapter will review the skin biopsy technique and recent findings with respect to diabetes.

Key concepts: Medicine, Skin biopsy, Cutaneous nerve, Nerve biopsy, Biopsy, Peripheral neuropathy, Diabetic neuropathy, Peripheral nerve

Related papers

Back to paper searchBrowse research topicsOriginal source
Punch Skin Biopsy in Diabetic Neuropathy — Research Paper | ScholarLens